OBOE IPR is majority owned by more than 30 researchers within Organic Bioelectronics – that is, research focusing on biological and medtech applications of organic materials with electronic and other such relevant functionalities. 

The company started in 2007 to handle patent rights and know-how coming out from research. At that time, the founding members were part of the OBOE research environment spanning expertise from Linköping University (in particular the Laboratory of Organic Electronics), the Karolinska Institute, the Swedish Royal Institute of Technology (KTH), and the Swedish national research institute RISE-Acreo. The environement was initially funded by the Swedish Foundation for Strategic Research (SSF) and later by Sweden’s innovation agency Vinnova.  

As of 2021, OBOE IPR has spun-off one company (Celluminova AB, in 2010) and oversees a patent portfolio consisting of 8 patent families.

Licensing and more information

Our IPR is made commercial through licensing and spin-off companies. For information about our patents or the various associated research projects, follow the links above or contact us directly.